pfizer biontech Archives

PFE Stock Rebounds, Pfizer Covid Vaccine Safe for Kids, Covid Is Officially America’s Deadliest Pandemic

Business News, Market News, News, Stocks, Story of the Day

By Darya Rudz Sep 21, 2021

Pfizer will submit the data received to the Food and Drug Administration (FDA) and other health regulators “as soon as possible.” However, it is unclear how much time the authorities will need to review the data and approve the vaccine.

PFE Stock Rises on FDA Authorization Pfizer COVID-19 Vaccine for Emergency Use, US to Immunize 100 Million by End of March

Business News, Market News, News, Stocks, Story of the Day

By Darya Rudz Dec 14, 2020

According to the FDA, Pfizer’s COVID-19 vaccine is given as two shots administered 21 days apart. One dose is to prime the body, and then a few weeks later, the second dose is to boost the response.

Pfizer CEO Sells 60% of His PFE Stock after COVID-19 Vaccine Proved to Be 90% Effective

Business News, Market News, News, Stocks, Wall Street

By Darya Rudz Nov 11, 2020

On the same day when Pfizer announced the results of the vaccine trial, the company’s CEO Albert Bourla sold 132,508 shares (or 62% of his stock) at the price of $41.99.

pfizer biontech

PFE Stock Rebounds, Pfizer Covid Vaccine Safe for Kids, Covid Is Officially America’s Deadliest Pandemic

PFE Stock Rises on FDA Authorization Pfizer COVID-19 Vaccine for Emergency Use, US to Immunize 100 Million by End of March

Pfizer CEO Sells 60% of His PFE Stock after COVID-19 Vaccine Proved to Be 90% Effective

Pfizer (PFE), BioNTech (BNTX) Stocks Posititively Reacted to Coronavirus Vaccine Trial